Try our Advanced Search for more refined results
September 30, 2013
Faig v. Bioscrip, Inc. et al
Case Number:
1:13-cv-06922
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Bernstein Litowitz
- Gibson Dunn
- Glancy Prongay
- Kirkland & Ellis
- Latham & Watkins
- Law Offices of Curtis V. Trinko
- O'Melveny & Myers
- Pomerantz LLP
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 27, 2017
BioScrip Investors' Attys Win $2.7M In Fees From $11M Deal
A New York federal judge on Wednesday granted Bernstein Litowitz Berger & Grossman LLP's request for $2.7 million in attorneys' fees from BioScrip Inc. after getting the specialty pharmacy to pay shareholders $10.9 million for allegedly lying about fraud tied to Novartis AG's iron-reducing drug Exjade.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login